Immunological aspects of benign melanocytic tumours and melanoma in situ
β Scribed by Neil I. Wilson; Alistair J. Cochran; Catherine E. Ross; Rona M. Mackie; Lindsay J. Ogg; Gaye Todd
- Book ID
- 104663845
- Publisher
- Springer-Verlag
- Year
- 1979
- Tongue
- English
- Weight
- 583 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Melanocyte-stimulating hormone (MSH) has been reported to enhance the experimental metastatic behaviour of melanoma cells in the mouse model. alpha-MSH production and MSH receptor (melanocortin 1 receptor gene) expression have been detected in cultured normal human melanocytes and metastasized melan
In an attempt to understand some of the natural immunological characteristics of cutaneous melanoma so that we can plan justifiable immunotherapeutic approaches, 23 patients were studied. The autologous leukocyte migration inhibition assay was utilized to assess in vitro their tumor-specific cellula
## Abstract The development of cutaneous malignant melanoma (CMM) and its precursor lesions, melanocytic nevi, has been linked to sun exposure. Cyclobutane pyrimidine dimers (CPDs) are the majority of DNA lesions induced by sun exposure. In our study, we investigated if CMM patients have impaired a